News

Published on 12 Dec 2021 on Insider Monkey via Yahoo Finance

Travere Therapeutics, Inc. (TVTX) Fell Out Of Favor With Hedge Funds?


Article preview image

We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of Travere Therapeutics, Inc. (NASDAQ:TVTX) based on that data.

Travere Therapeutics, Inc. (NASDAQ:TVTX) shares haven't seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 25 hedge funds' portfolios at the end of September. Our calculations also showed that TVTX isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings). The level and the change in hedge fund popularity aren't the only variables you need to analyze to decipher hedge funds' perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That's why at the end of this article we will examine companies such as Prelude Therapeutics Incorporated (NASDAQ:PRLD), GrowGeneration Corp. (NASDAQ:GRWG), and Day One Biopharmaceuticals Inc. (NASDAQ:DAWN) to gather more data points.

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. With all of this in mind let's take a look at the key hedge fund action regarding Travere Therapeutics, Inc. (NASDAQ:TVTX).

NASDAQ.PRLD price evolution
NYSE.HYLN price evolution
NASDAQ.GRWG price evolution
NYSE.KRA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
GrowGeneration Corp (GRWG) Q1 2022 Earnings Call Transcript

Image source: The Motley Fool. GrowGeneration Corp (NASDAQ: GRWG)Q1 2022 Earnings CallMay 10, 202...

Motley Fool 11 May 2022

GrowGeneration (GRWG) Q1 Earnings Miss, Trims '22 Outlook

GrowGeneration Corp. GRWG reported a loss per share of 9 cents in the first quarter of 2022, wide...

Zacks via Yahoo Finance 11 May 2022

GrowGeneration (GRWG) Reports Q1 Loss, Lags Revenue Estimates

GrowGeneration (GRWG) came out with a quarterly loss of $0.09 per share versus the Zacks Consensu...

Zacks via Yahoo Finance 10 May 2022

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Basic Materials Names

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a co...

Zacks via Yahoo Finance 4 May 2022

The Andersons (ANDE) Q1 Earnings Lag Estimates

The Andersons (ANDE) came out with quarterly earnings of $0.18 per share, missing the Zacks Conse...

Zacks via Yahoo Finance 3 May 2022

2 Ancillary Cannabis Stocks to Buy on the Dip and Hold

The downward trend for markets so far this year has had a disproportionate impact on cannabis...

Motley Fool 1 May 2022

Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Basic Materials Names

Two factors often determine stock prices in the long run: earnings and interest rates. Investors ...

Zacks via Yahoo Finance 29 Apr 2022

Bunge (BG) Surpasses Q1 Earnings and Revenue Estimates

Bunge (BG) came out with quarterly earnings of $4.26 per share, beating the Zacks Consensus Estim...

Zacks via Yahoo Finance 27 Apr 2022

GrowGeneration (GRWG) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, GrowGeneration (GRWG) closed at $6.68, marking a +1.21% move from ...

Zacks via Yahoo Finance 25 Apr 2022

Investing in Cannabis can Be Profitable with These 5 Tips

In recent years, more states have introduced measures designed to allow the use of cannabis. From...

FinanceBuzz via Yahoo Finance 22 Apr 2022